1. Home
  2. ALRS vs LXRX Comparison

ALRS vs LXRX Comparison

Compare ALRS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alerus Financial Corporation

ALRS

Alerus Financial Corporation

HOLD

Current Price

$29.39

Market Cap

715.4M

Sector

Finance

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.90

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALRS
LXRX
Founded
1879
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
715.4M
703.3M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
ALRS
LXRX
Price
$29.39
$1.90
Analyst Decision
Hold
Strong Buy
Analyst Count
6
2
Target Price
$25.40
$4.15
AVG Volume (30 Days)
155.1K
2.8M
Earning Date
04-29-2026
05-01-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
77.78
EPS
0.89
N/A
Revenue
N/A
$49,803,000.00
Revenue This Year
$38.42
N/A
Revenue Next Year
$4.68
N/A
P/E Ratio
$32.70
N/A
Revenue Growth
N/A
60.24
52 Week Low
$20.26
$0.64
52 Week High
$29.33
$2.53

Technical Indicators

Market Signals
Indicator
ALRS
LXRX
Relative Strength Index (RSI) 68.00 45.26
Support Level $23.13 $1.52
Resistance Level N/A $1.95
Average True Range (ATR) 0.67 0.13
MACD 0.01 -0.05
Stochastic Oscillator 90.74 19.39

Price Performance

Historical Comparison
ALRS
LXRX

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: